Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
1999 1
2000 1
2001 3
2005 2
2006 8
2007 4
2008 2
2010 1
2011 2
2012 2
2013 2
2014 2
2017 2
2018 1
2019 1
2020 1
2021 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Wireless electrostimulation: a new approach in combating infection?
Kambouris ME, Markogiannakis A, Arabatzis M, Manoussopoulos Y, Kantzanou M, Velegraki A. Kambouris ME, et al. Among authors: markogiannakis a. Future Microbiol. 2017 Mar;12:255-265. doi: 10.2217/fmb-2017-0157. Epub 2017 Feb 20. Future Microbiol. 2017. PMID: 28262048
Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors.
Psichogiou M, Poulakou G, Basoulis D, Paraskevis D, Markogiannakis A, Daikos GL. Psichogiou M, et al. Among authors: markogiannakis a. Curr Pharm Des. 2017;23(18):2552-2567. doi: 10.2174/1381612823666170329142059. Curr Pharm Des. 2017. PMID: 28356041 Review.
Treating infections caused by carbapenemase-producing Enterobacteriaceae.
Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. Tzouvelekis LS, et al. Among authors: markogiannakis a. Clin Microbiol Infect. 2014 Sep;20(9):862-72. doi: 10.1111/1469-0691.12697. Epub 2014 Jul 12. Clin Microbiol Infect. 2014. PMID: 24890393 Free article. Review.
Efficacy of Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against Infection from SARS-CoV-2 and Severe COVID-19 among Heavily Immunocompromised Patients: A Single-Center, Prospective, Real-World Study.
Basoulis D, Mastrogianni E, Karamanakos G, Gkoufa A, Georgakopoulou VE, Makrodimitri S, Gamaletsou MN, Markogiannakis A, Sipsas NV. Basoulis D, et al. Among authors: markogiannakis a. Viruses. 2024 Aug 22;16(8):1345. doi: 10.3390/v16081345. Viruses. 2024. PMID: 39205319 Free PMC article.
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial.
Davey RT Jr, Fernández-Cruz E, Markowitz N, Pett S, Babiker AG, Wentworth D, Khurana S, Engen N, Gordin F, Jain MK, Kan V, Polizzotto MN, Riska P, Ruxrungtham K, Temesgen Z, Lundgren J, Beigel JH, Lane HC, Neaton JD; INSIGHT FLU-IVIG Study Group. Davey RT Jr, et al. Lancet Respir Med. 2019 Nov;7(11):951-963. doi: 10.1016/S2213-2600(19)30253-X. Epub 2019 Sep 30. Lancet Respir Med. 2019. PMID: 31582358 Free PMC article. Clinical Trial.
Adaptive resistance to cationic compounds in Pseudomonas aeruginosa.
Skiada A, Markogiannakis A, Plachouras D, Daikos GL. Skiada A, et al. Among authors: markogiannakis a. Int J Antimicrob Agents. 2011 Mar;37(3):187-93. doi: 10.1016/j.ijantimicag.2010.11.019. Epub 2011 Feb 4. Int J Antimicrob Agents. 2011. PMID: 21295448 Review.
39 results